Abstract:Highly active lipogenesis is essential for rapid tumor growth. Sterol regulatory element-binding protein (SREBP) is a key transcriptional factor for lipogenesis and activated by reduced sterol and oxysterol levels. However, the mechanism by which cancer cells activate SREBP without altering these sterol/oxysterol levels remains elusive. In one of our recent studies published in Nature entitled "The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis", we demonstrated that activated AKT-mediated phosphoenolpyruvate carboxykinase 1 (PCK1) S90 phosphorylation reduces the gluconeogenic activity of PCK1 and triggers its translocation to the endoplasmic reticulum (ER), where PCK1 acts as a protein kinase and uses GTP, rather than ATP, as a phosphate donor to phosphorylate Insig1/2 thereby reducing oxysterol's binding to Insig1/2 and activating SREBP-mediated lipogenesis for tumor growth. These findings elucidate a coordinated regulation between gluconeogenesis and lipogenesis and uncover a critical role of the protein kinase activity of PCK1 in SREBP-dependent lipid synthesis.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **To reveal a new mechanism in which the metabolic enzyme PCK1 activates SREBP - dependent lipid synthesis by phosphorylating Insig1/2 in tumor cells, thereby promoting tumor growth**. Specifically, the paper mainly focuses on the following points: 1. **Background problems**: - Tumor cells rely on high - lipid metabolism to support rapid proliferation. - SREBP (sterol - regulatory - element - binding protein) is a key transcription factor that regulates lipid synthesis, and its activity is regulated by SCAP (SREBP cleavage - activating protein) and Insig (insulin - induced gene) proteins. - Under sterol - deficient conditions, SREBP is activated and transported to the Golgi apparatus for cleavage, and then enters the nucleus to initiate the expression of lipid - synthesis - related genes. 2. **Core problems of the study**: - The authors found that PCK1 (phosphoenolpyruvate carboxykinase 1), a metabolic enzyme usually involved in gluconeogenesis, can function as a protein kinase under certain conditions. - PCK1 phosphorylates Insig1/2, reduces the binding of oxysterol to Insig1/2, thereby relieving the inhibition of SREBP, activates the SREBP - dependent lipid - synthesis pathway, and ultimately promotes tumor growth. 3. **Key findings**: - AKT - mediated phosphorylation of PCK1 at the S90 site not only reduces the metabolic activity of PCK1 but also promotes its transfer from the cytoplasm to the endoplasmic reticulum. - Phosphorylated PCK1 uses GTP as a phosphate donor to specifically phosphorylate Insig1 at the S207 site and Insig2 at the S151 site. - This phosphorylation reduces the binding affinity of Insig1/2 to oxysterol, leading to the transport of SREBP from the endoplasmic reticulum to the Golgi apparatus and activation, thereby increasing the expression of lipid - synthesis - related genes. 4. **Clinical significance**: - In hepatocellular carcinoma (HCC) patient samples, the phosphorylation levels of PCK1 S90, Insig1 S207, and Insig2 S151, as well as the expression of nuclear SREBP1, are significantly increased, and the levels of these markers are negatively correlated with the survival time of patients. - These findings provide new ideas for the development of anti - cancer therapies targeting the protein - kinase activity of PCK1. In summary, this paper reveals a new function of PCK1 in regulating lipid synthesis through a non - classical pathway in tumor cells, emphasizes the important role of metabolic enzymes in tumor development, and provides potential targets for cancer treatment.

A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis

Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism

The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

Phosphoenolpyruvate Carboxykinase in Cell Metabolism: Roles and Mechanisms Beyond Gluconeogenesis.

Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma

P90 Ribosomal S6 Kinase Confers Cancer Cell Survival by Mediating Checkpoint Kinase 1 Degradation in Response to Glucose Stress

Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy

Metabolic Reprogramming by PCK1 Promotes TCA Cataplerosis, Oxidative Stress and Apoptosis in Liver Cancer Cells and Suppresses Hepatocellular Carcinoma

PCK1 activates oncogenic autophagy via down-regulation Serine phosphorylation of UBAP2L and antagonizes colorectal cancer growth

Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation

Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.

Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death

Pyruvate kinase M2 interacts with nuclear sterol regulatory element–binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma

Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma

Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression

Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism

PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway

Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation

PCK1 Negatively Regulates Cell Cycle Progression and Hepatoma Cell Proliferation Via the AMPK/p27Kip1 Axis

Acetylation of Pgk1 Promotes Liver Cancer Cell Proliferation and Tumorigenesis